Tony Huge

They Banned the Most Promising Anti-Aging Molecule on the Planet — Not Because It’s Dangerous, But Because a Pharma Company Wanted to Own It

Table of Contents

They Banned the Most Promising Anti-Aging Molecule on the Planet — Not Because It’s Dangerous, But Because a Pharma Company Wanted to Own It

By Tony Huge, J.D. — Medical Lawyer | March 2026


The Greatest Theft in Supplement History

In November 2022, the FDA quietly dropped a bombshell that most of America never heard about: they declared that NMN (Nicotinamide Mononucleotide) — a naturally occurring compound found in every living cell in your body — could no longer be sold as a dietary supplement.

Not because it hurt anyone. Not because a single person died. Not because a single hospitalization occurred. But because a pharmaceutical company called Metro Biotech wanted to develop it as a prescription drug, and you can’t have a $30 supplement competing with a future $500/month pharmaceutical.

Let that sink in. A molecule your body already produces. A molecule found in broccoli, avocados, and edamame. A molecule with over 100 published studies showing safety and efficacy for age-related decline. Banned from supplement shelves so a pharma company could patent a delivery method and charge you 15x more for it.

This isn’t about safety. This is about theft. And I’m going to prove it.


Who I Am and Why They Don’t Want Me Talking

My name is Tony Huge. I’m a medical lawyer with a J.D., and I’ve been called the most censored person in health, wellness, and fitness. Not because I spread misinformation — because I expose the systems designed to keep you aging, declining, and dependent on pharmaceutical interventions that manage symptoms instead of solving problems.

I’ve been deplatformed, investigated, and attacked because I believe in one thing the establishment cannot tolerate: your right to make informed decisions about your own body based on actual science, not corporate profit motives.

The NMN ban is one of the most egregious examples of regulatory capture I’ve seen in my career. And I’ve seen a lot.


What Is NMN and Why Does It Matter?

NMN is a precursor to NAD+ (Nicotinamide Adenine Dinucleotide) — a coenzyme found in every cell in your body that is essential for:

  • Energy metabolism: NAD+ is required for mitochondrial function. Without it, your cells cannot produce energy efficiently.
  • DNA repair: NAD+ activates sirtuins and PARP enzymes that repair damaged DNA — the fundamental mechanism of aging.
  • Cellular signaling: NAD+ regulates hundreds of metabolic processes including circadian rhythm, inflammation response, and stress resistance.
  • Neuroprotection: NAD+ levels directly correlate with cognitive function and neurological health.

Here’s the critical fact: NAD+ levels decline approximately 50% between ages 40 and 60. This decline is directly correlated with every hallmark of aging — metabolic dysfunction, cognitive decline, cardiovascular deterioration, immune system weakening, and cellular senescence.

NMN supplementation has been shown in peer-reviewed research to restore NAD+ levels, and with them, cellular function.


The Science They’re Hoping You Never Read

The mainstream narrative says NMN is “unproven.” Let me show you what the actual published research demonstrates:

Human Clinical Trials:

  • A 2022 randomized controlled trial in 80 middle-aged adults showed NMN supplementation (300mg/day) significantly increased blood NAD+ levels and improved physical performance metrics including walking speed and grip strength.
  • A 2021 study published in Science demonstrated that NMN supplementation improved insulin sensitivity in prediabetic women — a direct intervention for metabolic disease.
  • A 2022 clinical study showed NMN supplementation improved aerobic capacity in amateur runners, with significant improvements in oxygen utilization and exercise performance.
  • Multiple safety studies have confirmed that NMN at doses up to 1,200mg/day produces no serious adverse events in human subjects.

Preclinical Research (100+ studies):

  • Reversed age-related vascular dysfunction
  • Improved cognitive function in aging models
  • Restored mitochondrial function to youthful levels
  • Extended healthspan across multiple organ systems
  • Improved cardiac function and reduced cardiac inflammation
  • Enhanced DNA repair capacity

Safety Profile:

  • Deaths attributed to NMN supplementation: Zero
  • Serious adverse events in clinical trials: Zero
  • Organ toxicity documented: None
  • Drug interactions documented: Minimal

This is a compound with more safety data than most FDA-approved drugs had at the time of their approval. And they banned it from supplement shelves.


Why They Really Banned It: Follow the Money

The FDA’s justification for removing NMN from supplement status was Section 201(ff)(3)(B)(ii) of the Federal Food, Drug, and Cosmetic Act — a provision that says if a substance was first studied as a new drug before being marketed as a supplement, it cannot be sold as a supplement.

Metro Biotech (now MIB-626) filed an Investigational New Drug (IND) application for NMN in 2018. The FDA then used this IND filing to claim that NMN was being “investigated as a new drug” and therefore couldn’t be a supplement — despite the fact that NMN had been sold as a supplement for years before Metro Biotech ever filed anything.

This is the playbook:

  1. A pharma company identifies a profitable natural compound
  2. They file an IND application
  3. The FDA uses the IND to reclassify the natural compound as a “drug”
  4. Supplement companies are forced to pull the product
  5. The pharma company develops a patented version and charges 10-20x more

This is not conspiracy theory. This is documented regulatory procedure. And it happened to NMN in plain sight.

The Natural Products Association (NPA) and other industry groups challenged this decision. The NPA argued that NMN was marketed as a supplement before Metro Biotech’s IND filing, which should grandfather it in. The FDA disagreed. The pharmaceutical profit motive won.


The Laws of Biochemistry Physics: Why NMN Matters More Than They Want You to Know

In my book Better Than Natural, I established the Tony Huge Laws of Biochemistry Physics — principles that explain why the system opposes compounds that actually work. NMN is a perfect case study.

Law 1: A Day Natural Is a Day Wasted

NAD+ declines with age. That is a biological fact. Accepting that decline — accepting reduced energy, impaired DNA repair, accelerating aging — is accepting a diminished existence. Every day you allow your NAD+ levels to remain depleted is a day you’re operating below your biological potential.

The establishment wants you to believe that aging is inevitable and that “natural” decline should be accepted gracefully. I believe that’s a lie designed to keep you compliant. When a compound exists that can restore your cellular energy production to youthful levels, accepting decline is not wisdom — it’s surrender.

Law 4: Every Biological Problem Has a Chemical Solution

NAD+ decline is a biological problem. NMN is the chemical solution. The molecule exists. The research proves it works. The safety data confirms it’s well-tolerated. The only thing standing between you and this solution is a regulatory decision designed to protect pharmaceutical profits.

Your mitochondria don’t care about FDA classifications. Your sirtuins don’t care about IND applications. Your DNA repair enzymes don’t care about Metro Biotech’s business model. They need NAD+. NMN provides it. That’s biochemistry, not politics.

Law 5: The Law of Utility vs. Toxicity

NMN at therapeutic doses (250-1,200mg/day in human studies) shows remarkable utility — increased NAD+ levels, improved metabolic markers, enhanced physical performance — with essentially zero documented toxicity. The therapeutic window is enormous. The minimum effective dose produces measurable benefits. The maximum tested dose produces no adverse effects.

Compare this to statin drugs (prescribed to 40 million Americans): muscle pain in 10-25% of users, cognitive impairment, increased diabetes risk, liver enzyme elevation. Or to metformin (prescribed for metabolic dysfunction): GI side effects in 25-30% of users, B12 depletion, lactic acidosis risk.

NMN has a better safety profile than drugs your doctor prescribes without a second thought. But NMN is banned. The drugs with documented side effects remain on pharmacy shelves.


The Comparison That Exposes Everything

CompoundAnnual Deaths (USA)Serious Adverse EventsFDA Status
StatinsRhabdomyolysis deaths documentedMuscle pain (10-25%), cognitive effects, diabetes riskApproved, 40M+ users
MetforminLactic acidosis deaths documentedGI effects (25-30%), B12 depletionApproved, widely prescribed
Acetaminophen~500 annually56,000 ER visits/year, acute liver failureOTC Legal
NMN00 in clinical trialsBANNED as supplement

Read that table again. A compound with zero deaths and zero serious adverse events was removed from supplement shelves so a pharmaceutical company could develop it as a prescription drug. Meanwhile, compounds that kill hundreds and hospitalize tens of thousands remain freely available.

If this doesn’t prove that the system is designed around profit rather than safety, nothing will.


The System Is Built to Keep You Aging

Here’s the uncomfortable truth the anti-aging industry doesn’t want stated this clearly: the medical system profits from your decline.

An aging population with declining NAD+ levels develops:

  • Cardiovascular disease — $320 billion/year industry
  • Type 2 diabetes — $327 billion/year industry
  • Neurodegenerative disease — $305 billion/year industry
  • Cancer — $200+ billion/year industry

If NMN supplementation can slow or partially reverse the cellular mechanisms driving these conditions — and the published research suggests it can — then widespread NMN access threatens over a trillion dollars in annual medical revenue.

A healthy, energetic, cognitively sharp population doesn’t need the medical-pharmaceutical complex. That’s the threat NMN represents. Not danger to you. Danger to their business model.

And here’s the ultimate hypocrisy: the elites already use NAD+ therapy. IV NAD+ infusions are available at luxury wellness clinics in Beverly Hills, Miami, and Manhattan — for $750-$1,500 per session. The wealthy have access. You don’t. The supplement that cost $30-$50 per month was banned. The IV infusion that costs $1,000 per session continues unimpeded.

Two-tier medicine. The same story, every time.


The Path Forward

Despite the FDA’s classification, NMN remains available through various channels. Several companies continue to sell NMN by challenging the FDA’s interpretation or operating under different regulatory frameworks. International markets — particularly in Japan, where NMN research originated — continue to sell NMN freely as a health supplement.

The broader political landscape is shifting. Robert F. Kennedy Jr.’s stance on supplement access and medical freedom suggests potential regulatory reform. The growing body of human clinical trial data makes it increasingly difficult to justify NMN’s exclusion from the supplement market on scientific grounds.

What you should demand:

  • Reinstatement of NMN as a dietary supplement — the science supports it, the safety data confirms it, and the original ban was driven by corporate interest, not public health
  • Transparency in FDA-pharmaceutical relationships — when a company can effectively ban a natural compound by filing a drug application, the regulatory system is broken
  • Equal access to anti-aging interventions — NAD+ therapy shouldn’t be available only to those who can afford $1,000 IV sessions

Interesting Perspectives

The NMN ban is a landmark case, but it’s part of a larger pattern of regulatory capture. For a deeper look at how the system suppresses effective compounds, explore our analysis on the FDA’s targeting of the healing peptide BPC-157. The playbook is identical: target a promising, naturally-derived molecule to clear the field for a pharmaceutical version.

This battle extends beyond anti-aging. The same forces that banned NMN routinely attack the broader category of effective steroid alternatives and performance compounds, often using fear-mongering over supplement-drug interactions as a pretext. The goal is control, not safety.

For those seeking to optimize performance within the current constraints, understanding science-based pre-workout ingredients and exploring underground supplements that haven’t yet attracted regulatory attention is crucial. The fight for NMN is a fight for the principle that you have the right to access molecules that improve your health, especially when they are safer than many approved pharmaceuticals.


The Truth Is Non-Negotiable

NMN is one of the most researched, safest, and most promising anti-aging compounds ever discovered. It has zero documented deaths, zero serious adverse events in clinical trials, and a growing body of human evidence showing real benefits for metabolic health, physical performance, and cellular function.

It was banned not because it’s dangerous, but because it’s effective and inexpensive. The pharmaceutical industry cannot tolerate a $30 supplement that does what they want to charge $500/month for.

Your cells are declining right now. Your NAD+ levels are dropping. Your mitochondria are losing function. And the system that claims to protect your health just removed one of the most promising tools for addressing that decline — not for your safety, but for their profits.

That’s the truth. I don’t care if it gets me censored again. You deserve to know it.


Citations & References

  1. Yi, L., Maier, A. B., Tao, R., Lin, Z., Vaidya, A., Pendse, S., … & Declercq, J. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience, 45(1), 29-43. https://pubmed.ncbi.nlm.nih.gov/36482258/
  2. Yoshino, M., Yoshino, J., Kayser, B. D., Patti, G. J., Franczyk, M. P., Mills, K. F., … & Klein, S. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224-1229. https://pubmed.ncbi.nlm.nih.gov/34238308/
  3. Liao, B., Zhao, Y., Wang, D., Zhang, X., Hao, X., & Hu, M. (2022). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. Journal of the International Society of Sports Nutrition, 19(1), 54-67. https://pubmed.ncbi.nlm.nih.gov/34912839/
  4. Igarashi, M., Nakagawa-Nagahama, Y., Miura, M., Kashiwabara, K., Yaku, K., Sawada, M., … & Nakagawa, T. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging, 8(1), 5. https://pubmed.ncbi.nlm.nih.gov/33888596/
  5. Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metabolism, 27(3), 529-547. https://pubmed.ncbi.nlm.nih.gov/31250423/
  6. FDA. (2022, November). Response to NPA regarding NMN (Nicotinamide Mononucleotide) and its status as a dietary ingredient.
  7. Natural Products Association. (2022). Citizen Petition to FDA Regarding NMN. https://www.naturalproductsassoc.org

Tony Huge is a medical lawyer (J.D.) and author of Better Than Natural. This article represents analysis of peer-reviewed scientific literature and published regulatory documents. This is not medical advice. Consult with qualified healthcare providers before making decisions about compounds discussed herein.